Published Date: 20-11-2018
Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support
According to a new report Asia Pacific Dialysis Market, published by KBV research, the Asia Pacific Dialysis Market would witness market growth of 7.2% CAGR during the forecast period (2018 – 2024).
The In-center Dialysis market would dominate the Asia Pacific Dialysis Market by End User by 2024. The Home Dialysis market is expected to witness a CAGR of 8.2% during (2018 - 2024). The In-center Dialysis market is expected to witness a CAGR of 6.7% during (2018 - 2024).
The Services market dominated the Asia Pacific Dialysis Market by Products & Services in 2017. The Equipment market is expected to witness a CAGR of 6.8% during (2018 - 2024).
The Japan market dominated the Asia Pacific Hemodialysis Market by Country in 2017, and would achieve a market value of $5,491.2 million by 2024, growing at a CAGR of 4.6 % during the forecast period. The China market is expected to witness a CAGR of 7% during (2018 - 2024). Additionally, The India market is expected to witness a CAGR of 7.4% during (2018 - 2024).
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the mentioned countries. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Fresenius Medical Care Ag & Co. Kgaa, Baxter International, Inc., Davita Inc., Nipro Corporation, B. Braun Avitum Ag, Diaverum Deutschland Gmbh., Nikkiso Co. Ltd., Nxstage Medical, Inc., Cantel Medical Corporation (Medicators, Inc)., Asahi Kasei Corporation.
By End User
By Products & Services
Unique Offerings from KBV Research